Literature DB >> 22454248

A meta-analysis of proximal occlusion device outcomes in carotid artery stenting.

Robert M Bersin1, Eugenio Stabile, Gary M Ansel, Daniel G Clair, Alberto Cremonesi, L Nelson Hopkins, Dimitrios Nikas, Bernhard Reimers, Horst Sievert, Paolo Rubino.   

Abstract

BACKGROUND: The clinical risk predictors for adverse events in carotid stenting using distal embolic protection devices are well established and include patient age and symptomatic status. The risk predictors for adverse events with proximal occlusion devices are not as well established. This study is a meta-analysis of available data on proximal occlusion devices to determine the risk predictors of adverse events in carotid stenting.
METHODS: Study-specific results on 2,397 patients from six independent databases of two different proximal occlusion devices were meta-analyzed by an independent statistical analysis organization for predictors of 30-day major adverse clinical events including stroke, myocardial infarction, and death using random effects models. The primary endpoint was the composite of total stroke, myocardial infarction, and death at 30 days.
RESULTS: The incidence of stroke was 1.71%. The incidence of myocardial infarction was 0.02%. The incidence of death was 0.40%. The composite primary endpoint at 30 days was 2.25%. Age and diabetic status were found to be the only significant independent risk predictors; however, total stroke rates remained below 2.6% in all subgroups, including symptomatic octogenarians. The other baseline demographic variables including patient gender, symptomatic status, and contralateral carotid occlusion were not found to be independent risk predictors.
CONCLUSIONS: A meta-analysis of CAS procedures performed with proximal occlusion devices demonstrated a very low incidence of adverse events at 30 days. The only independent risk predictors were age and diabetes. Patient gender, symptomatic status, and other baseline characteristics were not found to be risk predictors for CAS using proximal occlusion devices.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22454248     DOI: 10.1002/ccd.24433

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  9 in total

Review 1.  Optimal treatment of extracranial carotid artery disease: carotid endarterectomy, carotid stenting, or optimal medical therapy.

Authors:  R Kevin Rogers; Kalkidan Bishu
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 2.  Carotid artery stenting: review of technique and update of recent literature.

Authors:  Sun Ho Ahn; Ethan A Prince; Gregory J Dubel
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

3.  Predictors of minor versus major stroke during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Authors:  Stephan Staubach; Ralph Hein-Rothweiler; Matthias Hochadel; Manuela Segerer; Ralf Zahn; Jens Jung; Gotthard Riess; Hubert Seggewiss; Andre Schneider; Thomas Fürste; Christian Gottkehaskamp; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2014-01-11       Impact factor: 5.460

4.  Short- and long-term major cardiovascular adverse events in carotid artery interventions: a nationwide population-based cohort study in Taiwan.

Authors:  Ming-Lung Tsai; Chun-Tai Mao; Dong-Yi Chen; I-Chang Hsieh; Ming-Shien Wen; Tien-Hsing Chen
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 5.  Carotid artery stenting: current and emerging options.

Authors:  Simon Morr; Ning Lin; Adnan H Siddiqui
Journal:  Med Devices (Auckl)       Date:  2014-10-20

Review 6.  Carotid Artery Stenting.

Authors:  Jae Hyeong Park; Jae Hwan Lee
Journal:  Korean Circ J       Date:  2017-11-15       Impact factor: 3.243

7.  Severe, recurrent in-stent carotid restenosis: endovascular approach, risk factors. Results from a prospective academic registry of 2637 consecutive carotid artery stenting procedures (TARGET-CAS).

Authors:  Łukasz Tekieli; Piotr Musiałek; Anna Kabłak-Ziembicka; Mariusz Trystuła; Tadeusz Przewłocki; Jacek Legutko; Karolina Dzierwa; Damian Maciejewski; Michał Michalski; Piotr Pieniążek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-08       Impact factor: 1.426

8.  Mid-term and late results of endovascular treatment for symptomatic carotid artery stenosis under proximal protection.

Authors:  Paweł Latacz; Marian Simka; Marcin Krzanowski; Katarzyna Krzanowska; Paweł Brzegowy; Bartłomiej Łasocha; Tadeusz J Popiela
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-04-20       Impact factor: 1.195

9.  Low Common Carotid Artery Systolic Occlusion Pressure and Symptomatic Carotid Artery Stenosis Are Associated with Development of Neurologic Intolerance during Proximal Protected Carotid Artery Stenting.

Authors:  Hee Jin Kwon; Jae Hyeong Park; Jae Hwan Lee; Hye Seon Jeong; Hee Jung Song; Jei Kim; Mijoo Kim; In Sun Kwon; In Whan Seong
Journal:  Korean Circ J       Date:  2018-03       Impact factor: 3.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.